Download MIIN Meeting Program 2006 - Lorne Infection and Immunity

Lorne Infection and Immunity Conference 2017
Preliminary Program – Subject to change
Mantra Lorne, 15-17 February 2017
Wednesday, February 15, 2017
12:00-13:00
Registration
13:00-13:10
Welcome + opening remarks
13:10-15:00
Session 1: Host - Pathogen Interactions
13.10-13.40
Thierry Soldati, University of Geneva
Infecting Amoebae with Mycobacteria to Study Conserved Mechanisms of Cellular
Innate Defences
13.40-14.00
Cynthia Whitchurch, University of Technology, Sydney
Roles of bacterial morphotype plasticity in infection
Wai-Hong Tham, Walter and Eliza Hall Institute
14.00-14.15
14.15-14.30
Malaria parasite invasion, versatile structural scaffolds and alternate erythrocyte
receptors
Amit Singhal, Singapore Immunology Network
Reprograming host immune-metabolic circuits for restricting TB
Matthew J Sullivan, Griffith University
14.30-14:45
14.45-15.00
The Streptococcus agalactiae virulence regulator CovR affects the pathogenesis of
urinary tract infection
Thomas Naderer, Monash University
Targeting host cell death factors in infections
15:00-15:30
Afternoon tea
15:30-17:30
Session 2: Regulation of immunity
15.30-16.00
Bali Pulendran, Emory Vaccine Centre
Systems Vaccinology: enabling rational vaccine design with systems biological
approaches.
16.00-16.20
David Lynn, South Australian Health and Medical Research Institute
Interplay between the microbiome, vaccines and the immune system
Sam Forster, Wellcome Trust Sanger Institute
16.20-16:35
16.35-16.50
Culturing 'unculturable' human gastrointestinal microbiota provides phenotypic insights
for bacteriotherapy design
Ben Wade, Deakin University
MicroRNA; a telltale sign of stress?
16:50-17:30
~12x3min student talks
17.30-18.30
Break
18:30-20:00
Dinner – Mantra Lorne
20:00-21:30
Poster Session I
Thursday, February 16, 2017
7:00-8:30
Breakfast
7:15-8:15
Jomar Life Research Breakfast Workshop
8:30-10:05
Session 3: Pathogenesis and Prevention of Viral Infections
8.30-9:00
George Gao, Chinese Academy of Sciences
TBC
9:00-9.20
Katherine Kedzierska, University of Melbourne
Immunity to the newly emerged A/H7N9 influenza virus
9.20-9.35
Stephen Rawlinson, University of Melbourne
Hendra virus matrix protein localises to sub-nucleolar puncta, interacts with treacle and
inhibits rRNA production
9.35-9:50
David Thomas, Monash University
Nuclear trafficking of Venezuelan Equine Encephalitis Virus capsid protein as an antiviral
target
9:50-10:05
Natalie Borg, Monash University
Characterisation of Hendra virus V protein interactions with human nuclear transport
receptors reveals opportunities to target Hendra virus infection
10:05-10:35
Morning tea
10:35-12:10
Session 4: Innate Immunity to Infection
10.35-11.05
Sonja Best, BNIH Rocky Mountain Laboratories, NIAID/NIH
Move over retroviruses: restriction of flavivirus replication by human TRIM5a
11.05-11.25
Sammy Bedoui, University of Melbourne
The role of microbiota in regulating CD8+ T cell memory
11:25-11:40
11.40-11.55
11.55-12.10
Si Ming Man, Australian National University
Interferon-inducible proteins are essential for the activation of the inflammasomes
Anthony Sadler, Hudson Institute and Monash Medical Centre
MDA5 limits rotavirus infection but promotes cell death and inflammation in the pancreas
Amelia Soderholm, University of Queensland
Interaction of Group A Streptococcus with innate immune pathways
12:10-13:20
Lunch
12.15-13.15
Early Career Researcher Lunch
12.15-13.15
AVS Annual General Meeting
13:20-14:40
Session 5: Inflammation and Infectious Diseases
13.20-13.50
Caroline Demangel, Institut Pasteur
Host immunomodulation by Mycobacterium ulcerans, the causative agent of Bairnsdale
ulcer
13.50-14.10
Connie Wong, Monash University
Translocation and dissemination of commensal bacteria in post-stroke infection
14.10-14.25
Bin Wei, Chinese Academy of Sciences
STK4 regulates TLR pathways and protects against chronic inflammation–related
hepatocellular carcinoma
Nollaig Bourke, Hudson Institute of Medical Research
14.25-14.40
Characterising the novel regulation and function of interferon epsilon in the female
reproductive tract
14.40-15:10
Afternoon tea
15:10-16:20
Session 6: ECR Session
15.10-15.25
VIIN Career Development Award Winner: Marcel Doerflinger, Walter and Eliza Hall
Institute
Utilizing in vitro CRISPR/Cas9 screening platforms for functional genomics to decipher
host cell death mechanisms in chronic and acute infectious diseases
15.25-15.40
VIIN Career Development Award Winner: Michaela Finsterbusch, Monash University
Monocytes contribute to neutrophil-dependent kidney injury in acute glomerulonephritis
15.40-16.20
~12x3min ECR talks
16:20-17:00
Break
17:00-18:30
Session 7: Plenary
17:00-17:15
VIIN Young Investigator Award Winner: Charlotte Nejad, Hudson Institute of Medical
Research
Type-I Interferon dependent degradation of microRNA isoforms in mouse macrophages
17.15-17.30
VIIN Young Investigator Award Winner: Rhys Grinter, Monash University
The structural basis of bacterial iron piracy from host ferredoxin
17.30-18.30
Plenary: Dominique Soldati-Favre, Geneva Medical School
Apicomplexan aspartyl proteases play fundamental roles in establishment of parasitism
18:30-20:00
Dinner – Lorne Hotel
20:00-21:30
Poster Session II
Friday, February 17, 2017
7:00-8:30
Breakfast and check out
8:30-10:20
Session 8: Adaptive Immunity to Infection
8.30-9.00
Marion Pepper, University of Washington
Understanding Plasmodium-specific B cells
9.00-9.20
David Tscharke, Australian National University
A CD8+ T cell-eye view of virus infection
9.20-9.35
9.35-9:50
Julian Vivian, Monash University
MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape
Susan Christo, University of Melbourne
Differential programming shapes tissue-resident memory T cells in distinct environments
9:50-10.05
Simone Park, University of Melbourne
Spontaneous formation and protective potential of tumour-specific tissue-resident
memory T cells
10:05-10:20
Timothy Wells, University of Queensland Diamantina Institute
Paradoxical antibody: The scope and treatment of antibody that exacerbates Gram-
negative infections
10:20-10:50
Morning Tea
10:50-12:55
Session 9: Vaccines, Therapeutics and Diagnostics
10.50-11.20
Nancy Haigwood, Oregon Health and Science University
The critical role of antibodies in HIV transmission, immunity, and vaccine development
11.20-11.40
Rowena Martin, Australian National University
The role of an essential parasite-encoded transporter in the digestion of host cell
proteins
11.40-11:55
11.55-12.10
Stephen Kent, University of Melbourne
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection
Larissa Dirr, Griffith University
Challenges in inhibitor design for human parainfluenza virus type-3 - The butterfly effect
Cody Allison, Walter and Eliza Hall Institute
12.10-12.25
12:25-12:40
12.40-12.55
The clinical stage SMAC-mimetic, birinapant, specifically sensitises HIV-infected CD4+ T
cells to death, reducing viraemia and time-to-rebound in anti-retroviral treated
humanised mice
Kate Markey, QIMR Berghofer Medical Resarch Institute
Towards a rapid molecular test for diagnosis and prediction of blood stream infection
Diana Quan, University of Sydney
Natural products as novel therapies for tuberculosis
12.55-13.00
Closing remarks
13:00-
Depart